Target intelligence / Profile preview

Biotin carboxylase enzyme (BC)

Target
BC
Molecular classification
Enzyme, Carboxylase domain/component, Biotin-dependent enzyme
01

Overview

Biotin carboxylase is a highly conserved enzyme domain central to the catalysis of biotin-dependent carboxylases such as acetyl-CoA carboxylase, propionyl-CoA carboxylase, pyruvate carboxylase, methylcrotonyl-CoA carboxylase, and urea carboxylase. This domain catalyzes the ATP-dependent carboxylation of biotin, a critical step in the transfer of carboxyl groups to various substrates as part of multi-domain enzyme complexes. Biotin carboxylase activity is essential for pathways including fatty acid biosynthesis, gluconeogenesis, amino acid metabolism, and others. As a drug target, its inhibition has therapeutic and agrochemical potential, especially via targeting the broader carboxylase complexes it is part of. Mutations or inhibition of these enzymes can have clinical significance in cancer, metabolic syndromes, congenital disorders, and infectious diseases.

Other names
Biotin-dependent carboxylase domainBC domain
02

Mechanism of action

Inhibition of the carboxylation reaction: Drugs/herbicides inhibit ATP-dependent carboxylation of biotin, blocking fatty acid biosynthesis or related pathways

03

Biological functions

Fatty acid biosynthesisCarbohydrate metabolismAmino acid metabolismPolyketide biosynthesisUrea utilization (in specific bacteria)
04

Disease associations

Cancer (especially via Acetyl-CoA carboxylase)Obesity and type 2 diabetes (Acetyl-CoA carboxylase is a drug target)Infection (target for antimicrobial agents; herbicides target the plant/plastid ACC complex)Inborn errors of metabolism (mutations in propionyl-CoA carboxylase [PCC], methylcrotonyl-CoA carboxylase [MCC], or pyruvate carboxylase [PC] lead to metabolic diseases in humans)
05

Safety considerations

Broad inhibition may interfere with essential metabolism: Targeting biotin carboxylase could have off-target effects, leading to disrupted fatty acid synthesis and metabolic disordersGenetic mutations affecting biotin carboxylase complexes can cause severe inborn errors of metabolism
06

Interacting drugs

Herbicides: Target plant acetyl-CoA carboxylase, which includes biotin carboxylase activity

1 more in the full profile.

07

Biomarkers

Genetic mutations in human PCC, MCC, or PC genes can be diagnostic for inherited metabolic diseasesPossibly decreased/enzyme activity in metabolic or infectious disease contexts

Beyond the preview

Go deeper on Biotin carboxylase enzyme (BC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotin carboxylase enzyme (BC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call